BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2871210)

  • 1. Effects of somatostatin on muscarinic acetylcholine receptor binding in the rat hippocampus.
    Miyoshi R; Kito S; Mizuno K; Matsubayashi H
    Jpn J Pharmacol; 1986 Feb; 40(2):291-6. PubMed ID: 2871210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
    Sharif NA; Williams GW; DeSantis LM
    Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the effect of somatostatin on muscarinic receptors selective to M1 type?
    Miyoshi R; Kito S; Mizuno K; Matsubayashi H
    Brain Res; 1986 Jul; 377(2):348-50. PubMed ID: 2873870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of guanine nucleotide-induced reductions in muscarinic agonist binding to rabbit ileal submucosal membranes by lidamidine and tetracaine.
    Bleakman D; Naftalin RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):366-72. PubMed ID: 2900471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes.
    Liebmann C; Nawrath S; Schnittler M; Schubert H; Jakobs KH
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):7-15. PubMed ID: 1538792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies.
    Cortés R; Palacios JM
    Brain Res; 1986 Jan; 362(2):227-38. PubMed ID: 3942874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of paired M2 muscarinic receptors.
    Potter LT; Ballesteros LA; Bichajian LH; Ferrendelli CA; Fisher A; Hanchett HE; Zhang R
    Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of quinidine on rat heart muscarinic receptors.
    Waelbroeck M; De Neef P; Robberecht P; Christophe J
    Life Sci; 1984 Sep; 35(10):1069-76. PubMed ID: 6482646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bretylium tosylate binds preferentially to muscarinic receptors labelled with [3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex.
    Gillard M; Brunner F; Waelbroeck M; Svoboda M; Christophe J
    Eur J Pharmacol; 1989 Jan; 160(1):117-24. PubMed ID: 2714357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diethyl ether effects on muscarinic acetylcholine receptor complexes in rat brainstem.
    Anthony BL; Dennison RL; Narayanan TK; Aronstam RS
    Biochem Pharmacol; 1988 Nov; 37(21):4041-6. PubMed ID: 3142483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of halothane on high affinity agonist binding and guanine nucleotide sensitivity of muscarinic acetylcholine receptors from brainstem of rat.
    Dennison RL; Anthony BL; Narayanan TK; Aronstam RS
    Neuropharmacology; 1987 Aug; 26(8):1201-5. PubMed ID: 3116449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic binding sites on bovine pulmonary arterial endothelial cells in culture.
    Aronstam RS; Ryan US; Catravas JD
    Pharmacology; 1992; 44(6):324-33. PubMed ID: 1508962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J; Chuang DM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors.
    Harden TK; Meeker RB; Martin MW
    J Pharmacol Exp Ther; 1983 Dec; 227(3):570-7. PubMed ID: 6317839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite effects of alcuronium on agonist and on antagonist binding to muscarinic receptors.
    Maass A; Mohr K
    Eur J Pharmacol; 1996 Jun; 305(1-3):231-4. PubMed ID: 8813558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of verapamil on the binding properties of rat heart muscarinic receptors: evidence for an allosteric site.
    Waelbroeck M; Robberecht P; De Neef P; Christophe J
    Biochem Biophys Res Commun; 1984 May; 121(1):340-5. PubMed ID: 6732812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic cholinergic receptor subtype on frog esophageal peptic cells: binding and secretion studies.
    Dickinson KE; Matsumoto H; Anderson W; Pruitt RE; Uemura N; Hirschowitz BI
    J Pharmacol Exp Ther; 1988 Sep; 246(3):879-86. PubMed ID: 2901489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.